4.7 Article

Biodistribution of 99mTc-PLA/PVA/Atezolizumab nanoparticles for non-small cell lung cancer diagnosis

Related references

Note: Only part of the references are listed.
Article Pharmacology & Pharmacy

The use of Lamivudine-loaded PLGA nanoparticles in the diagnosis of lung cancer: Preparation, characterization, radiolabeling with 99mTc and cell binding

Meliha Ekinci et al.

Summary: Lung cancer is the leading cause of death globally, and early detection remains a challenge. This study developed a new drug that can efficiently accumulate and image lung cancer.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2022)

Review Immunology

Nanoparticle-Induced Complement Activation: Implications for Cancer Nanomedicine

Ninh M. La-Beck et al.

Summary: Nanoparticle-based anticancer medications offer advantages such as targeted-drug delivery and reduced toxicity, but may lead to complement activation that affects drug efficacy. Chronic complement activation induced by nanoparticles may reduce the antitumor efficacy of drugs, calling for further research into this phenomenon.

FRONTIERS IN IMMUNOLOGY (2021)

Article Oncology

Cancer statistics, 2020

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

Review Biochemistry & Molecular Biology

Polymeric Nanoparticles: Production, Characterization, Toxicology and Ecotoxicology

Aleksandra Zielinska et al.

MOLECULES (2020)

Review Endocrinology & Metabolism

Prognostic and predictive value of nuclear imaging in endocrine oncology

Giorgio Treglia et al.

ENDOCRINE (2020)

Article Pharmacology & Pharmacy

Radioactive polymeric nanoparticles for biomedical application

Shentian Wu et al.

DRUG DELIVERY (2020)

Review Chemistry, Inorganic & Nuclear

Technetium-99m metastable radiochemistry for pharmaceutical applications: old chemistry for new products

Bianca Costa et al.

JOURNAL OF COORDINATION CHEMISTRY (2019)

Editorial Material Oncology

Lung Cancer Worldwide

Alex A. Adjei

JOURNAL OF THORACIC ONCOLOGY (2019)

Review Medicine, General & Internal

Immune Checkpoint Inhibitor Toxicities

Julian A. Marin-Acevedo et al.

MAYO CLINIC PROCEEDINGS (2019)

Article Radiology, Nuclear Medicine & Medical Imaging

Future of Theranostics: An Outlook on Precision Oncology in Nuclear Medicine

Thomas Langbein et al.

JOURNAL OF NUCLEAR MEDICINE (2019)

Article Biotechnology & Applied Microbiology

Diagnosing lung cancer using etoposide microparticles labeled with 99mTc

Roberto Salvi et al.

ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2018)

Article Engineering, Biomedical

Dose calculation of radioactive nanoparticles: first considerations for the Design of Theranostic Agents

Ralph Santos-Oliveira et al.

BIOMEDICAL MICRODEVICES (2018)

Review Oncology

PD-L1 Expression in Lung Cancer

Hui Yu et al.

JOURNAL OF THORACIC ONCOLOGY (2016)

Article Pharmacology & Pharmacy

Methotrexate loaded chitosan nanoparticles: Preparation, radiolabeling and in vitro evaluation for breast cancer diagnosis

Meliha Ekinci et al.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2015)

Article Oncology

PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients

A. D'Incecco et al.

BRITISH JOURNAL OF CANCER (2015)

Article Nanoscience & Nanotechnology

Development of Novel Nanoparticle for Bone Cancer

Beatriz Ferreira de Carvalho Patricio et al.

JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2014)

Review Radiology, Nuclear Medicine & Medical Imaging

Review of functional/anatomical imaging in oncology

Stephanie N. Histed et al.

NUCLEAR MEDICINE COMMUNICATIONS (2012)

Review Oncology

The Evolving Role of Histology in the Management of Advanced Non-Small-Cell Lung Cancer

Corey J. Langer et al.

JOURNAL OF CLINICAL ONCOLOGY (2010)

Review Oncology

The molecular epidemiology of lung cancer

Ann G. Schwartz et al.

CARCINOGENESIS (2007)

Review Respiratory System

Diagnostic imaging of lung cancer

N Hollings et al.

EUROPEAN RESPIRATORY JOURNAL (2002)